These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26137607)

  • 1. Regulating compounding pharmacies.
    Noble A
    NCSL Legisbrief; 2015 Jun; 23(23):1-2. PubMed ID: 26137607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of outsourcing facilities in overcoming drug shortages.
    Mattingly AN
    J Am Pharm Assoc (2003); 2021; 61(1):e110-e114. PubMed ID: 32943335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.
    Miller DG
    Int J Pharm Compd; 2014; 18(2):117-8. PubMed ID: 24881114
    [No Abstract]   [Full Text] [Related]  

  • 4. The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.
    Int J Pharm Compd; 2014; 18(3):208. PubMed ID: 25306767
    [No Abstract]   [Full Text] [Related]  

  • 5. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating compounding pharmacies after NECC.
    Outterson K
    N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
    [No Abstract]   [Full Text] [Related]  

  • 7. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could State Regulations be the Next Frontier in Preemption Jurisprudence? Drug Compounding as a Case Study.
    Brown NA; Tomar E
    Food Drug Law J; 2016; 71(2):271-99. PubMed ID: 29140058
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA inspections find unsafe practices in compounding pharmacies.
    McCarthy M
    BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476
    [No Abstract]   [Full Text] [Related]  

  • 10. Compounding errors.
    Drazen JM; Curfman GD; Baden LR; Morrissey S
    N Engl J Med; 2012 Dec; 367(25):2436-7. PubMed ID: 23134355
    [No Abstract]   [Full Text] [Related]  

  • 11. Outsourcing facilities and their place in the U.S. drug supply chain.
    Gianturco SL; Yoon S; Yuen MV; Mattingly AN
    J Am Pharm Assoc (2003); 2021; 61(1):e99-e102. PubMed ID: 32863181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Registrations of compounding outsourcing facilities trickle in.
    Thompson CA
    Am J Health Syst Pharm; 2014 Mar; 71(5):350, 352. PubMed ID: 24534584
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 14. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug compounding, drug safety, and the first amendment.
    Dresser R
    Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulating Compounding Pharmacies.
    Noble A
    NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The drug quality and security act: how will it change pharmacy?
    Soukup BJ
    Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.